Kaiser Health News and Daily Beast, November 3, 2019. More caution is warranted as the FDA keeps brand-name drugs on the fast path to the market, despite concerns about manufacturing and pre-market inspections.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
When Recalls Fail: Many harmful products remain in homes and stores. Why that happens, what needs to change, and how to protect yourself.
Consumer Reports, October 31, 2019. Whether it be contaminated food, deadly infant sleepers, breast implants, or other unsafe products, recalls are not protecting us as well as they should be.
Read More »FDA calls for new warnings for breast implants
The Washington Post, October 23, 2019. Due to problems with breast implants, FDA calls for new warnings associated with the implants as well as providing more information about the devices.
Read More »Women Should Be Warned of Breast Implant Hazards, F.D.A. Says
NY Times, October 23, 2019. In light of breast implant hazards, FDA proposes that surgeons discuss the risks with patients and that manufacturers print bold warnings on the device packaging.
Read More »Dr. Diana Zuckerman’s Statement on FDA’s Draft Guidance on Labeling for Breast Implants
October 23, 2019. The FDA’s draft includes the types of information that we have proposed to the FDA in recent months in our work with patient advocates and plastic surgeons. The devil is in the details, so we look forward to working with the FDA to finalize these materials so that patients can make better informed decisions in the future than most women considering breast implants have been able to make.
Read More »